This industry needs a first mover. And if a first-mover happened, the whole dynamics of the industry would change. And I think there are enormous financial gains that would be available for such a first mover. CaP CURE has made a difference, but it hasn't made enough of a difference. To spread this into the treatment of hundreds of thousands of people per year requires scale and requires educational programs and requires deployment programs that are way outside of scope of research institutions and research efforts, which is what CAP CURE is devoted to.
Industry needs to get into the act.
For more impartial information, I rely on Car and Driver magazine. I rely on Consumer Reports, I rely on conversations with other people who have experienced cost-brand comparisons. Unfortunately, what I found in my encounter with the medical establishment is very similar. People advocate what they knew, what they were comfortable with, or they had experience with, and they were very unfamiliar with and unaggressive in promoting, if you wish, the other brands. And there was no Consumer Reports.